Fertile grounds in Asia for private equity investments in healthcare

Singapore

THERE has never been a better time to raise money for Asian companies in the life sciences sector as the Covid-19 pandemic exposes cracks in the healthcare systems and distribution channels, forcing many in healthcare and insurance to seek innovative solutions.

Industry professionals including AXA chief digital and transformation officer Tomasz Kurczyk; Novartis Philippines country corporate affairs head Christine Fajardo; and healthcare industry expert Rahul Bibhuti recently spoke at a webinar by Isentia that the healthcare landscape is undergoing rapid changes and seeing plenty of new opportunities.